Millennium Management’s Aegerion Pharmaceuticals AEGR Stock Holding History

Millennium Management’s Portfolio AEGR Stock Details AEGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-52,500	Closed	-$3.73M	–	4144
2013 Q4	$3.73M	Buy	+52,500	New	+$4.01M	0.01%	1386

Millennium Management's AEGR Position: Q4 2016 in Review

Millennium Management sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 165,879 shares — an estimated $493K sold.

Millennium Management first reported a position in AEGR in Q2 2013 and held it in 14 quarters. The position peaked at $32M in Q4 2014. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

Millennium Management reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Millennium Management sold 165,879 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $493K.
Millennium Management first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 14 quarters.
Millennium Management's Aegerion Pharmaceuticals position peaked at $32M in Q4 2014.
0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.